BMS Plans Appeal After Sandoz And Teva Eliminate UK Eliquis Patent

UK Ruling Saw Local Counterpart Of European Apixaban Patent Declared Invalid

 
• By David Wallace
  
UK law litigation court ruling gavel legal case appeal
Apixaban has this month been the subject of a decision, an appeal and further litigation • Source: Alexey Panferov / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin